Hybrid management of aberrant subclavian artery: A systematic review and meta-analysis

Abstract

Objective: To elucidate the short- and long-term mortality, morbidity, and endoleak incidences in the hybrid management of aberrant subclavian artery (ASA). Methods: A systematic review and meta-analysis of 99 articles comprising n = 272 cases using PRISMA were supplemented by Cohen’s Kappa for assessor consistency. The analysis involved a random-effect model, odds ratios (ORs) with 95% confidence intervals, tests of heterogeneity, and probability. This review was registered with the International Prospective Register of Systematic Reviews (CRD42023405011). Results: The 30-day mortality was 4.6% (95% CI: 1.4%–14.4%) with an overall mortality of 7.3% (95% CI: 2.9%–18.7%) demonstrating a 1.2% increase in mortality per decade of life beyond 60 years. The reported morbidity was 7.6% (95% CI: 3.7%–15.7%) and higher in males albeit higher age (p